tweenvest

MindMaze Therapeutics Holding SA (SWX: MMTX)

Health Care · Biotechnology · CH

CHF0.14

-5.55% today · -92.7% 1Y

Public summary
A free snapshot of MindMaze Therapeutics Holding SA, with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

MindMaze Therapeutics Holding SA (SWX: MMTX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $28.43M and employs 10 people.

Over the last twelve months the share price has lost 92.7%, trading between 0.13 and 2.92.

Tweenvest scores MindMaze Therapeutics Holding SA across four factors: quality 58/100. Its strongest factor is quality.

MMTX price history

Dec 19, 2025 · 2.12Weekly closes 0.13 – 2.26Nov 12, 2026 · 0.14

Key figures

Market cap
$28.43M
Revenue (TTM)
$1.48M
P/E
—
EPS
-0.48
Dividend yield
—
Beta (5Y)
—
52-week high
CHF2.92
52-week low
CHF0.13
Avg volume (3M)
—
Shares outstanding
169.99M
Employees
10
Next earnings
—

About MindMaze Therapeutics Holding SA

MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outpatient and home settings; MindMotion Companion, an application that manages prescription, monitoring and documentation across MindMaze Therapeutics’ neurotherapeutics ecosystem; and the patient app, a patient-facing mobile application, that supports clinic-to-home continuity by making prescribed therapy easy to follow outside the clinic. It also provides Izar hand therapy device which supports fine motor rehabilitation; Physilog sensor, a wearable inertial sensing device designed to quantify human movement; toaprun, a training for Parkinson’s therapy-reimagined through play. The company was founded in 2012 and is headquartered in Geneva, Switzerland.

ISIN
CH1251125998
Founded
2012
Listed since
Dec 15, 2025
Exchange
SIX Swiss Exchange
Currency
CHF
CompanyMarket capPriceDay
Mendus AB (publ)OM: IMMU$28.73MSkr4.49-8.37%
Poltreg S.A.WSE: PTG$28.68Mzł19.30+0.78%
Biomark Diagnostics Inc.DB: 20B$28.67M€0.240.00%
Pelthos Therapeutics Inc.NYSEAM: PTHS$28.48M$7.44-7.35%
Amplia Therapeutics LimitedASX: ATX$28.42MAU$0.08-1.20%
Microbix Biosystems Inc.TSX: MBX$28.29MCA$0.30+1.72%
Edesa Biotech, Inc.NasdaqCM: EDSA$28.10M$2.08-6.31%
ProMIS Neurosciences, Inc.NasdaqCM: PMN$28.07M$3.13-2.49%

Browse every Biotechnology company →